165 related articles for article (PubMed ID: 27607483)
1. Can clinical characteristics be criteria to perform chromosomal microarray analysis in children and adolescents with autism spectrum disorders?
Sys M; van den Bogaert A; Roosens B; Lampo A; Jansen A; Wouters S; Keymolen K
Minerva Pediatr; 2018 Jun; 70(3):225-232. PubMed ID: 27607483
[TBL] [Abstract][Full Text] [Related]
2. Chromosomal Microarray Analysis as a First-Tier Clinical Diagnostic Test in Patients With Developmental Delay/Intellectual Disability, Autism Spectrum Disorders, and Multiple Congenital Anomalies: A Prospective Multicenter Study in Korea.
Jang W; Kim Y; Han E; Park J; Chae H; Kwon A; Choi H; Kim J; Son JO; Lee SJ; Hong BY; Jang DH; Han JY; Lee JH; Kim SY; Lee IG; Sung IK; Moon Y; Kim M; Park JH
Ann Lab Med; 2019 May; 39(3):299-310. PubMed ID: 30623622
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal Microarray Analysis of Consecutive Individuals with Autism Spectrum Disorders Using an Ultra-High Resolution Chromosomal Microarray Optimized for Neurodevelopmental Disorders.
Ho KS; Wassman ER; Baxter AL; Hensel CH; Martin MM; Prasad A; Twede H; Vanzo RJ; Butler MG
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941670
[TBL] [Abstract][Full Text] [Related]
4. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
[TBL] [Abstract][Full Text] [Related]
5. Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation.
Hu T; Zhang Z; Wang J; Li Q; Zhu H; Lai Y; Wang H; Liu S
Biomed Res Int; 2019; 2019():9352581. PubMed ID: 31781653
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal microarray testing influences medical management.
Coulter ME; Miller DT; Harris DJ; Hawley P; Picker J; Roberts AE; Sobeih MM; Irons M
Genet Med; 2011 Sep; 13(9):770-6. PubMed ID: 21716121
[TBL] [Abstract][Full Text] [Related]
7. Genetic profile and clinical application of chromosomal microarray in children with intellectual disability in Hong Kong.
Chan PY; Luk HM; Lee FM; Lo IF
Hong Kong Med J; 2018 Oct; 24(5):451-459. PubMed ID: 30262673
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
[TBL] [Abstract][Full Text] [Related]
9. Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil.
Chaves TF; Baretto N; Oliveira LF; Ocampos M; Barbato IT; Anselmi M; De Luca GR; Barbato Filho JH; Pinto LLC; Bernardi P; Maris AF
Sci Rep; 2019 Nov; 9(1):17776. PubMed ID: 31780800
[TBL] [Abstract][Full Text] [Related]
10. Routine chromosomal microarray analysis is necessary in Korean patients with unexplained developmental delay/mental retardation/autism spectrum disorder.
Shin S; Yu N; Choi JR; Jeong S; Lee KA
Ann Lab Med; 2015 Sep; 35(5):510-8. PubMed ID: 26206688
[TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnostic Yield of Chromosomal Microarray Analysis and Whole-Exome Sequencing in Children With Autism Spectrum Disorder.
Tammimies K; Marshall CR; Walker S; Kaur G; Thiruvahindrapuram B; Lionel AC; Yuen RK; Uddin M; Roberts W; Weksberg R; Woodbury-Smith M; Zwaigenbaum L; Anagnostou E; Wang Z; Wei J; Howe JL; Gazzellone MJ; Lau L; Sung WW; Whitten K; Vardy C; Crosbie V; Tsang B; D'Abate L; Tong WW; Luscombe S; Doyle T; Carter MT; Szatmari P; Stuckless S; Merico D; Stavropoulos DJ; Scherer SW; Fernandez BA
JAMA; 2015 Sep; 314(9):895-903. PubMed ID: 26325558
[TBL] [Abstract][Full Text] [Related]
12. Clinical genetic testing for patients with autism spectrum disorders.
Shen Y; Dies KA; Holm IA; Bridgemohan C; Sobeih MM; Caronna EB; Miller KJ; Frazier JA; Silverstein I; Picker J; Weissman L; Raffalli P; Jeste S; Demmer LA; Peters HK; Brewster SJ; Kowalczyk SJ; Rosen-Sheidley B; McGowan C; Duda AW; Lincoln SA; Lowe KR; Schonwald A; Robbins M; Hisama F; Wolff R; Becker R; Nasir R; Urion DK; Milunsky JM; Rappaport L; Gusella JF; Walsh CA; Wu BL; Miller DT;
Pediatrics; 2010 Apr; 125(4):e727-35. PubMed ID: 20231187
[TBL] [Abstract][Full Text] [Related]
13. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
Miller DT; Adam MP; Aradhya S; Biesecker LG; Brothman AR; Carter NP; Church DM; Crolla JA; Eichler EE; Epstein CJ; Faucett WA; Feuk L; Friedman JM; Hamosh A; Jackson L; Kaminsky EB; Kok K; Krantz ID; Kuhn RM; Lee C; Ostell JM; Rosenberg C; Scherer SW; Spinner NB; Stavropoulos DJ; Tepperberg JH; Thorland EC; Vermeesch JR; Waggoner DJ; Watson MS; Martin CL; Ledbetter DH
Am J Hum Genet; 2010 May; 86(5):749-64. PubMed ID: 20466091
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis.
Mademont-Soler I; Morales C; Soler A; Martínez-Crespo JM; Shen Y; Margarit E; Clusellas N; Obón M; Wu BL; Sánchez A
Ultrasound Obstet Gynecol; 2013 Apr; 41(4):375-82. PubMed ID: 23233332
[TBL] [Abstract][Full Text] [Related]
15. Benefit versus risk of chromosomal microarray analysis performed in pregnancies with normal and positive prenatal screening results: A retrospective study.
Moshonov R; Hod K; Azaria B; Abadi-Korek I; Berger R; Shohat M
PLoS One; 2021; 16(4):e0250734. PubMed ID: 33901244
[TBL] [Abstract][Full Text] [Related]
16. Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage: a systematic review and meta-analysis.
Dhillon RK; Hillman SC; Morris RK; McMullan D; Williams D; Coomarasamy A; Kilby MD
BJOG; 2014 Jan; 121(1):11-21. PubMed ID: 23859082
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal microarray analysis in a cohort of underrepresented population identifies SERINC2 as a novel candidate gene for autism spectrum disorder.
Hnoonual A; Thammachote W; Tim-Aroon T; Rojnueangnit K; Hansakunachai T; Sombuntham T; Roongpraiwan R; Worachotekamjorn J; Chuthapisith J; Fucharoen S; Wattanasirichaigoon D; Ruangdaraganon N; Limprasert P; Jinawath N
Sci Rep; 2017 Sep; 7(1):12096. PubMed ID: 28935972
[TBL] [Abstract][Full Text] [Related]
18. A cohort study of neurodevelopmental disorders and/or congenital anomalies using high resolution chromosomal microarrays in southern Brazil highlighting the significance of ASD.
Chaves TF; Ocampos M; Barbato IT; de Camargo Pinto LL; de Luca GR; Barbato Filho JH; Bernardi P; Costa Netto Muniz Y; Francesca Maris A
Sci Rep; 2024 Feb; 14(1):3762. PubMed ID: 38355898
[TBL] [Abstract][Full Text] [Related]
19. The clinical use of chromosomal microarray analysis in detection of fetal chromosomal rearrangements: a study from China Mainland.
Wu Y; Wang Y; Tao J; Han X; Zhao X; Liu C; Gao L; Cheng W
Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():44-50. PubMed ID: 28340467
[TBL] [Abstract][Full Text] [Related]
20. Comparative yield of molecular diagnostic algorithms for autism spectrum disorder diagnosis in India: evidence supporting whole exome sequencing as first tier test.
Sheth F; Shah J; Jain D; Shah S; Patel H; Patel K; Solanki DI; Iyer AS; Menghani B; Mhatre P; Mehta S; Bajaj S; Patel V; Pandya M; Dhami D; Patel D; Sheth J; Sheth H
BMC Neurol; 2023 Aug; 23(1):292. PubMed ID: 37543562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
